Search
for
Sort by
Research 331–360 of 1000+
- Targeting of Smoothened for therapeutic gain
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- Molecular Genetics of the PI3K-AKT-mTOR Pathway in Genodermatoses: Diagnostic Implications and Treatment Opportunities
- Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Epidermal γδ T cells, CD8 T cells and macrophages are increased in number in alopecia areata and express BST2 as part of an interferon-driven antiviral gene signature
- Cholesterol promotes hair growth through activating sympathetic nerves and enhancing the proliferation of hair follicle stem cells
- <i>In vivo </i>CD44‐CD49d complex formation in autoimmune disease has consequences on T cell activation and apoptosis resistance
- 802 Molecular effect of brepocitinib in hidradenitis suppurativa (HS)
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Poster Presentations
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Recent Advances in Drug Development for Hair Loss
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study